Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?

Abstract Women overdue for cervical cancer screening often have other preventive care gaps. We examined whether mailing unsolicited human papillomavirus (HPV) self-sampling kits to increase cervical cancer screening impacted receipt of other preventive services women were due for: mammography, colorectal cancer (CRC) screening, influenza vaccination, depression screening, and diabetic HbA1c monitoring. From 2014 to 2016, 16,590 underscreened women were randomized to receive a mailed kit or usual care Pap reminders within Kaiser Permanente Washington. We used logistic regression to estimate odds ratios (ORs) of preventive services receipt within 12-months between the intervention vs. control arms, and within the intervention arm (comparing those returning a kit vs. attending Pap vs. nothing), adjusting models for demographic variables. There were no significant between-arm differences in uptake of any of the preventive services: intervention vs. control: mammography OR = 1.01 (95% confidence interval:0.88–1.17), CRC screening OR = 0.98 (0.86–1.13), influenza vaccination OR = 0.99 (0.92–1.06), depression screening OR = 1.07 (0.99–1.16), HbA1c OR = 0.84 (0.62–1.13). Within the intervention arm, preventive services uptake was higher in women who completed cervical cancer screening vs. did not, with stronger effects for women who attended Pap: Pap vs. nothing: mammography OR = 11.81 (8.11–17.19), CRC screening OR = 7.31 (5.57–9.58), influenza vaccination OR = 2.06 (1.82–2.32), depression screening OR = 1.79 (1.57–2.05), HbA1c OR = 3.35 (1.49–7.52); kit vs. nothing: mammography OR = 2.26 (1.56–3.26), CRC screening OR = 5.05 (3.57–7.14), influenza vaccination OR = 1.67 (1.41–1.98), depression screening OR = 1.09 (0.89–1.33), HbA1c OR = 1.23 (0.57–2.65). Mailing HPV self-sampling kits to underscreened women did not negatively impact uptake of other preventive services. However, overall preventive service uptake was the highest among women who attended in-clinic cervical cancer screening.